This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.



Jerrold F. Rosenbaum, M.D.

Published: December 1, 1997

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Given the limitations of research to address the complexity of patient care,clinicians continue to rely heavily on consensus among experts for questions other than those on the specific efficacy of one treatment over another. Inparticular, choices of treatments, the "how to’s " of prescribing, difficult patientand treatment issues and settings, and options for nonresponders all are addressedthrough dialogue among experts. Similarly, our understanding of theneurobiology of disorders, while growing, is still incomplete and awaits cluesthat will come from examining genetic differences between those affected andthose not affected by specific disorders.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 58

Quick Links: Psychiatry

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...